(Approval lapsed) NARDIL Phenelzine Sulfate Tablets USP 15mg
Section 19A approved medicine
(Approval lapsed) NARDIL Phenelzine Sulfate Tablets USP 15mg
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
NARDIL phenelzine 15mg (as sulfate) tablet bottle - ARTG 93600
Indication(s)
NARDIL (phenelzine sulfate) is indicated in the treatment of depressed patients clinically characterized as "atypical", "nonendogenous" or "neurotic". These patients often have mixed anxiety and depression and phobic or hypochondriacal features. There is less conclusive evidence of its usefulness for severely depressed patients with endogenous features. NARDIL is indicated for patients who have failed to respond to the drugs more commonly used for these conditions.